Clinical Trial Update: Neisseria Meningitidis Burden of Disease Study

View source ↗

Summary

GlaxoSmithKline-sponsored burden-of-disease trial focusing on Neisseria meningitidis has completed. The study also concerns infections caused by Streptococcus p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Infection
• Meningococcal Meningitis
• Pneumococcal Disease

Snippet

Sponsor: GlaxoSmithKline | Conditions: Streptococcus Pneumoniae, Neisseria Meningitidis | Status: COMPLETED